Progenity
General Information | |
Business: |
We are a biotechnology company with an established track record of success in developing and commercializing molecular testing products as well as innovating in the field of precision medicine. We believe that we are a market-leading provider of in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making critical and timely medical decisions during various life stages, such as family planning, pregnancy, or navigating a complex disease diagnosis. |
Industry: | MEDICAL LABORATORIES |
Employees: | 674 |
Founded: | 2012 |
Contact Information | |
Address | 4330 La Jolla Village Drive, Suite 200, San Diego, CA 92122, US |
Phone Number | (855) 293-2639 |
Web Address | http://www.progenity.com |
View Prospectus: | Progenity |
Financial Information | |
Market Cap | $677.4mil |
Revenues | $113.3 mil (last 12 months) |
Net Income | $-141.2 mil (last 12 months) |
IPO Profile | |
Symbol | PROG |
Exchange | NASDAQ |
Shares (millions): | 6.7 |
Price range | $15.00 - $15.00 |
Est. $ Volume | $100.0 mil |
Manager / Joint Managers | Piper Sandler/ Wells Fargo Securities |
CO-Managers | Baird/ Raymond James/ BTIG |
Expected To Trade: | 6/19/2020 |
Status: | Priced |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |